Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10716786 Transmucosal and subcutaneous compositions

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

Golden AI

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12128043 Pharmaceutical capsules comprising lumateperone mono-tosylate

Edits on 23 Oct, 2024

"update inverses"

Golden AI

edited on 23 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12122792 Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders

Edits on 18 Sep, 2024

"update inverses"

Golden AI

edited on 18 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12090155 Methods

Edits on 28 Aug, 2024

"update inverses"

Golden AI

edited on 28 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12070459 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

Edits on 3 Jul, 2024

"update inverses"

Golden AI

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12023331 Methods

Edits on 15 May, 2024

"update inverses"

Golden AI

edited on 15 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11980617 Methods of treating acute depression and/or acute anxiety

Edits on 17 Apr, 2024

"update inverses"

Golden AI

edited on 17 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11958852 Compounds and methods

"update inverses"

Golden AI

edited on 17 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11957791 Methods

Edits on 5 Oct, 2023

"update inverses"

Golden AI

edited on 5 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11773095 Organic compounds

Edits on 13 Sep, 2023

"update inverses"

Golden AI

edited on 13 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11753419 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders

Edits on 5 Jul, 2023

"update inverses"

Golden AI

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11690842 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

Edits on 19 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 19 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=107167860

Edits on 28 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 28 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11052083 Transmucosal methods for treating psychiatric and neurological conditions

Edits on 31 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 31 Mar, 2023

Infobox

Patent Citations

‌

US Patent 10072010 Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity

Edits on 29 Mar, 2023

"Entity importer update"

Golden AI

edited on 29 Mar, 2023

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107167860

Date of Patent

July 21, 2020

Patent Application Number

159348600

Date Filed

March 23, 2018

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=107167860

Patent Citations

‌

US Patent 10072010 Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity

‌

US Patent 10077267 Organic compounds

‌

US Patent 10117867 Methods and compositions for sleep disorders and other disorders

Patent Citations Received

‌

US Patent 11052083 Transmucosal methods for treating psychiatric and neurological conditions

Patent Primary Examiner

‌

Raymond J. Henley, III

Edits on 20 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 20 Mar, 2023

Infobox

Patent Citations

‌

US Patent 10117867 Methods and compositions for sleep disorders and other disorders

Edits on 25 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 25 Sep, 2022

Infobox

Patent Citations

‌

US Patent 10117867 Methods and compositions for sleep disorders and other disorders

Edits on 23 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 23 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 11052083 Transmucosal methods for treating psychiatric and neurological conditions

Edits on 8 Jun, 2022

"Entity importer update"

Golden AI

edited on 8 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=10716786

Edits on 12 Feb, 2022

"update inverses"

Golden AI

edited on 12 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11052083 Transmucosal methods for treating psychiatric and neurological conditions

Find more entities like US Patent 10716786 Transmucosal and subcutaneous compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API